Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wang Lihuai"'
Publikováno v:
Open Medicine, Vol 18, Iss 1, Pp 1367-80 (2023)
The stress response molecule nuclear protein‑1 (NUPR1) is essential for the growth of multiple types of human malignant tumor cells. However, the significance of NUPR1 in lung cancer is still not entirely elucidated. Therefore, this study is aimed
Externí odkaz:
https://doaj.org/article/fe2e05a2021c418fa447beb12ac8cc79
Publikováno v:
Am J Transl Res
Objective: This study was designed to explore the clinical effect of cold and heat ablation on patients with advanced lung cancer (LC) and its influence on immune function. Methods: Data of 104 cases of advanced LC treated between July 2015 and April
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8585f6145f9e260f3314830dc3294540
https://europepmc.org/articles/PMC10182500/
https://europepmc.org/articles/PMC10182500/
Autor:
Sun, Yinhui, Wang, Lihuai, Deng, Changqing, Liu, Hua, Guo, Zhongcong, Chang, Zelin, Mo, Jianxiong
Publikováno v:
Tropical Journal of Pharmaceutical Research; Vol. 20 No. 3 (2021); 519-524
Purpose: To investigate the role of nuclear protein 1 (NUPR1) in the drug resistance of non-small cell lung cancer (NSCLC) and its regulatory mechanisms. Methods: Quantitative polymerase chain reaction (qPCR) and immunoblot assays were conducted to d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang L; Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China., Sun T; Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China., Yang X; Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China., Wen Z; Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China., Sun Y; Department of Pathophysiology, Medical College, Hunan University of Traditional Chinese Medicine, Changsha 410208, Hunan Province, China., Liu H; Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.
Publikováno v:
Current computer-aided drug design [Curr Comput Aided Drug Des] 2024 Jan 17. Date of Electronic Publication: 2024 Jan 17.
Autor:
Cheng R; Department of Vascular and Neoplastic Intervention, The First Affiliated Hospital of Hunan University of Chinese Medicine No. 95, Middle Shaoshan Road, Changsha 410007, Hunan, China., Li Y; Department of Vascular and Neoplastic Intervention, The First Affiliated Hospital of Hunan University of Chinese Medicine No. 95, Middle Shaoshan Road, Changsha 410007, Hunan, China., Su L; Department of Vascular and Neoplastic Intervention, The First Affiliated Hospital of Hunan University of Chinese Medicine No. 95, Middle Shaoshan Road, Changsha 410007, Hunan, China., Wang L; Department of Oncology, The First Affiliated Hospital of Hunan University of Chinese Medicine No. 95, Middle Shaoshan Road, Changsha 410007, Hunan, China., Cao Y; Department of Vascular and Neoplastic Intervention, The First Affiliated Hospital of Hunan University of Chinese Medicine No. 95, Middle Shaoshan Road, Changsha 410007, Hunan, China.
Publikováno v:
American journal of translational research [Am J Transl Res] 2023 Apr 15; Vol. 15 (4), pp. 2939-2948. Date of Electronic Publication: 2023 Apr 15 (Print Publication: 2023).